ARGOS THERAPEUTICS INC 4 SEC Filings

Filed On	Filing
25 Apr 2018	Form 4: Abbey Jeffrey D, Director Returned 67,887 shares to the issuer
25 Apr 2018	Form 4: Katz Richard D, Vice President and CFO Returned 22,629 shares to the issuer
25 Apr 2018	Form 4: Harrelson Lori R., Vice President of Finance Returned 22,629 shares to the issuer
25 Apr 2018	Form 4: Nicolette Charles A., CSO and Vice President of R&D Returned 27,150 shares to the issuer
02 Apr 2018	Form 4: Katz Richard D, Vice President and CFO Received 22,629 shares as a grant or award
30 Mar 2018	Form 4: Harrelson Lori R., Vice President of Finance Received 22,629 shares as a grant or award
30 Mar 2018	Form 4: Nicolette Charles A., CSO and Vice President of R&D Received 27,150 shares as a grant or award
30 Mar 2018	Form 4: Abbey Jeffrey D, Director Received 67,887 shares as a grant or award
12 Jan 2018	Form 4: Harrelson Lori R., Vice President of Finance Sold 64,329 shares ($10.6K)
12 Jan 2018	Form 4: Nicolette Charles A., CSO and Vice President of R&D Sold 100,250 shares ($16.5K)
12 Jan 2018	Form 4: Abbey Jeffrey D, Director Sold 124,987 shares ($20.6K)
12 Jan 2018	Form 4: Katz Richard D, Vice President and CFO Sold 104,435 shares ($17.2K)
05 Jan 2018	Form 4: Abbey Jeffrey D, Director Sold 114,702 shares ($18.7K)
05 Jan 2018	Form 4: Katz Richard D, Vice President and CFO Sold 101,228 shares ($16.5K)
05 Jan 2018	Form 4: Nicolette Charles A., CSO and Vice President of R&D Sold 92,001 shares ($15.1K)
05 Jan 2018	Form 4: Harrelson Lori R., Vice President of Finance Sold 59,072 shares ($9.66K)
05 Jan 2018	Form 4: Abbey Jeffrey D, Director Sold 114,702 shares ($18.7K)
02 Nov 2017	Form 4: Pharmstandard International S.a., 10% owner and 1 other Disposed of 99,495 shares (Other Transaction) ($79.2M)
28 Sep 2017	Form 4: Morrison Richard G, Director Granted 30,000 Stock Option (right to buy)
31 Aug 2017	Form 4: Harrelson Lori R., Vice President of Finance Received 320,683 shares as a grant or award

Comments